IRIS

1.1 Articolo su rivista: [71164] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.461 a 1.480 di 71.164
Titolo Data di pubblicazione Autore(i) File
Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer 1-gen-2019 Mennini, Fs; Marcellusi, A; Fabiano, G; Rimassa, L; Santoro, A; Personeni, N
Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date 1-gen-2019 Personeni, N; Pressiani, T; Rimassa, L
Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery? 1-gen-2018 Vigano, L; Darwish, Ss; Rimassa, L; Cimino, M; Carnaghi, C; Donadon, M; Procopio, F; Personeni, N; Del Fabbro, D; Santoro, A; Torzilli, G
Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients 1-gen-2022 Milana, Flavio; Famularo, Simone; Luberto, Antonio; Rimassa, Lorenza; Scorsetti, Marta; Comito, Tiziana; Pressiani, Tiziana; Franzese, Ciro; Poretti, Dario; Di Tommaso, Luca; Personeni, Nicola; Rodari, Marcello; Pedicini, Vittorio; Donadon, Matteo; Torzilli, Guido
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications 1-gen-2016 Personeni, N; Baretti, M; Bozzarelli, S; Spaggiari, P; Rubino, L; Tronconi, Mc; Fumagalli, U; Rosati, R; Giordano, L; Roncalli, M; Santoro, A; Rimassa, L
Biomarkers in hepatocellular carcinoma - Letter 1-gen-2012 Personeni, N.; Rimassa, L.; Santoro, A.
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 1-gen-2022 Rimini, Margherita; Burgio, Valentina; Antonuzzo, Lorenzo; Rimassa, Lorenza; Oneda, Ester; Lavacchi, Daniele; Personeni, Nicola; Ratti, Francesca; Pedica, Federica; Della Corte, Angelo; Persano, Mara; De Cobelli, Francesco; Aldrighetti, Luca; Scartozzi, Mario; Cascinu, Stefano; Casadei-Gardini, Andrea
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomized, placebo-controlled phase 2 study 1-gen-2013 Santoro, A; Rimassa, L; Borbath, I; Daniele, B; Salvagni, S; Van Laethem, J L; Van Vlierberghe, H; Trojan, J; Kolligs, F T; Weiss, A; Miles, S; Gasbarrini, A; Lencioni, M; Cicalese, L; Sherman, M; Gridelli, C; Buggisch, P; Gerken, G; Schmid, R M; Boni, C; Personeni, N; Hassoun, Z; Abbadessa, G; Schwartz, B; Von Roemeling, R; Lamar, M E; Chen, Y; Porta, C
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer : a safe and effective approach 1-gen-2014 Comito, T.; Cozzi, L.; Clerici, E.; Campisi, M. C.; Liardo, R. L. E.; Navarria, P.; Ascolese, A.; Tozzi, A.; Iftode, C.; De Rose, F.; Villa, E.; Personeni, N.; Rimassa, L.; Santoro, A.; Fogliata, A.; Mancosu, P.; Tomatis, S.; Scorsetti, M.
Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells 1-gen-2001 We, Carson; R, Parihar; Mj, Lindemann; Personeni, N.; J, Dierksheide; Nj, Meropol; J, Baselga; Ma, Caligiuri
Hepatocellular carcinoma: a global disease in need of individualized treatment strategies 1-gen-2017 Personeni, N; Rimassa, L
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection 1-gen-2024 Macagno, Marco; Pessei, Valeria; Congiusta, Noemi; Lazzari, Luca; Bellomo, Sara Erika; Idrees, Fariha; Cavaliere, Alessandro; Pietrantonio, Filippo; Raimondi, Alessandra; Gusmaroli, Eleonora; Zampino, Maria Giulia; Gervaso, Lorenzo; Ciardiello, Davide; Mondello, Giuseppe; Santoro, Armando; Personeni, Nicola; Bonoldi, Emanuela; Aquilano, Maria Costanza; Valtorta, Emanuele; Siena, Salvatore; Sartore-Bianchi, Andrea; Amatu, Alessio; Bonazzina, Erica Francesca; Bencardino, Katia Bruna; Serini, Guido; Marsoni, Silvia; Barault, Ludovic; Di Nicolantonio, Federica; Maione, Federica
Response prediction to EGFR-targeted therapies in colorectal cancer 1-gen-2006 Personeni, N.; S, Tejpar; E., Van Cutsem
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study 1-gen-2018 Rimassa, L.; Assenat, E.; Peck-Radosavljevic, M.; Pracht, M.; Zagonel, V.; Mathurin, P.; Rota Caremoli, E.; Porta, C.; Daniele, B.; Bolondi, L.; Mazzaferro, V.; Harris, W.; Damjanov, N.; Pastorelli, D.; Reig, M.; Knox, J.; Negri, F.; Trojan, J.; López López, C.; Personeni, N.; Decaens, T.; Dupuy, M.; Sieghart, W.; Abbadessa, G.; Schwartz, B.; Lamar, M.; Goldberg, T.; Shuster, D.; Santoro, A.; Bruix, J.
Sorafenib in hepatitis C-virus negative patients with hepatocellular carcinoma: don’t throw the baby out with the bathwater 1-gen-2017 Personeni, N; Rimassa, L; Giordano, L; Santoro, A
Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date 1-gen-2019 Personeni, N; Pressiani, T; Rimassa, L
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study 1-gen-2015 Personeni, N; Rimassa, L; Verusio, C; Barni, S; Rubino, L; Bozzarelli, S; Villa, E; Carnaghi, C; Tronconi, Mc; Gerardi, C; Galli, F; Floriani, I; Destro, A; Raschioni, C; Labianca, R; Santoro, A
The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges 1-gen-2021 D'Alessio, Antonio; Prete, Maria Giuseppina; Cammarota, Antonella; Personeni, Nicola; Rimassa, Lorenza
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma 1-gen-2019 Mazzaferro, V.; El-Rayes, B.; Droz Dit Busset, M.; Cotsoglou, C.; Harris, W.; Damjanov, N.; Masi, G.; Rimassa, L.; Personeni, N.; Braiteh, F.; Zagonel, V.; Papadopoulos, K.; Hall, T.; Wang, Y.; Schwartz, B.; Kazakin, J.; Bhoori, S.; De Braud, F.; Shaib, W.
Cabozantinib in patients with hepatocellular carcinoma failing previous treatment with sorafenib 1-gen-2019 Personeni, N.; Pressiani, T.; Rimassa, L.
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.461 a 1.480 di 71.164
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Articolo su rivista71162
  • 2 Contributo in volume (Capitolo ...1
  • 7 Altro1
Autore
  • ESPOSITO, Susanna Maria Roberta1170
  • NICCOLI, GIAMPAOLO491
  • DI MARIO, Francesco481
  • LORENZINI, Giulio421
  • TISEO, Marcello396
  • VENTURA, Marco371
  • RIZZOLI, Corrado370
  • BIGNAMI, Elena Giovanna363
  • CALZETTA, Luigino354
  • SVERZELLATI, Nicola353
Data di pubblicazione
  • In corso di stampa66
  • 2020 - 202616403
  • 2010 - 201922952
  • 2000 - 200918285
  • 1990 - 19998873
  • 1980 - 19893844
  • 1970 - 1979711
  • 1965 - 196930
Editore
  • MDPI965
  • Elsevier Ltd746
  • Elsevier B.V.640
  • MDPI AG497
  • Elsevier386
  • Springer316
  • John Wiley and Sons Inc314
  • Multidisciplinary Digital Publish...296
  • Springer Science and Business Med...288
  • Elsevier Inc.261
Rivista
  • ACTA BIO-MEDICA DE L'ATENEO PARMENSE933
  • PLOS ONE381
  • ANNALI DELLA FACOLTÀ DI MEDICINA ...348
  • SCIENTIFIC REPORTS272
  • AREA262
  • INTERNATIONAL JOURNAL OF MOLECULA...192
  • DOCTOR. OS183
  • ACTA BIOMEDICA181
  • NUTRIENTS179
  • PHYSICAL REVIEW. B, CONDENSED MAT...169
Serie
  • KEY ENGINEERING MATERIALS1
Keyword
  • Humans2902
  • Female1593
  • Male1490
  • Middle Aged900
  • Adult893
  • Aged757
  • Animals652
  • Italy585
  • Medicine (all)464
  • COVID-19451
Lingua
  • eng42929
  • ita9076
  • fre232
  • spa124
  • ger99
  • und61
  • enm49
  • rus41
  • grc33
  • por33
Accesso al fulltext
  • no fulltext57853
  • reserved8054
  • open3765
  • partially open822
  • restricted667
  • embargoed2
  • mixed1